Particle.news

Download on the App Store

Coldrif Cough Syrup Deaths Rise to 22 as Sresan Owner Is Arrested and WHO Probes Export Risk

Government tests confirmed extreme diethylene glycol contamination that forced regulators to pull the syrup.

Overview

  • Two children being treated in Nagpur died on Wednesday, taking the toll linked to Coldrif to 22, with several others still hospitalized and five reported critical.
  • Madhya Pradesh police arrested Sresan Pharmaceuticals owner Ranganathan Govindan in Chennai and are seeking transit remand, while the Kancheepuram unit remains sealed and an SIT leads the probe.
  • WHO said India informed it that the contaminated syrups were not exported, flagged a screening gap for domestically sold syrups, and is weighing whether a global medical products alert is warranted.
  • Tamil Nadu’s lab reported about 48.6% diethylene glycol in a Coldrif batch, CDSCO found unbilled DEG containers at the factory, and authorities have moved to cancel the manufacturer’s licence.
  • States have banned or recalled Coldrif and issued stop‑use notices for Respifresh TR and ReLife, with regulators ordering wider checks and removal of stocks from sale.